JPRN-UMIN000033577招募中未知
Efficacy and safety of tolvaptan in patients with severe aortic stenosis and chronic kidney disease undergoing transcatheter aortic valve replacement - TOlvaptan in Patients with severe aortic Stenosis undergoing Transcatheter Aortic valve Replacement (TOPSTAR)
Tokyo Women's Medical University0 个研究点目标入组 40 人开始时间: 2018年7月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who violate the following criteria are excluded from this study 1 Patients receiving hemodialysis therapy 2 patients already taking tolvaptan 3 Patients with difficult oral medication 4 Patients who do not feel dry mouth 5 Those whose serum sodium level measured within 24 hours before the start of the study drug exceeds 150 mEq / ml 6 In addition, patients whose research managers judged inappropriate as subjects
研究者
相似试验
已完成
不适用
Efficacy and safety of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failuresevere chronic kidney disease complicated by congestive heart failureJPRN-UMIN000029787Department of Nephrology, Nippon Medical School50
招募中
1 期
Efficacy and safety of tolvaptan for patients with ascites after liver resection, prospective study(Efficacy and safety of tolvaptan after liver resection, prospective study)JPRN-jRCTs061220114Ohdan Hideki30
招募中
不适用
Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventionalJPRN-UMIN000008712Division of Kidney and Hypertension, the Jikei University School of Medicine40
招募中
不适用
A Study of efficacy of Tolvaptan for Patients with Chronic Heart Failurechronic heart failureJPRN-UMIN000009897Department of Medicine II, Kansai Medical University,20
已完成
不适用
A Trial of the effect of tolvaptan on patients with nephrotic state and chronic heart failureJPRN-UMIN000011763Shonan Kamakura General Hospital20